BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3 AND Clinical Outcome
64 results:

  • 1. Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study.
    Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Carus A; Rosenvilde JJ; Berney D; Daugaard G
    Eur J Cancer; 2024 May; 202():114025. PubMed ID: 38531266
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic Factors for Relapse in Patients With clinical Stage I testicular Seminoma: A Nationwide, Population-Based Cohort Study.
    Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Rosenvilde JJ; Berney D; Daugaard G
    J Clin Oncol; 2024 Jan; 42(1):81-89. PubMed ID: 37683134
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor outcome in Male Malignant Germ Cell Tumors.
    Timmerman DM; Eleveld TF; Sriram S; Dorssers LCJ; Gillis AJM; Schmidtova S; Kalavska K; van de Werken HJG; Oing C; Honecker F; Mego M; Looijenga LHJ
    J Clin Oncol; 2022 Sep; 40(26):3077-3087. PubMed ID: 35442716
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Diagnosis and treatment of 21-hydroxylase deficiency with testicular adrenal rest tumors:a report of three cases and literature review].
    Zhang Q; Zang L; Zhang CY; Gu WJ; Li B; Jia XF; Chen K; Pei Y; Du J; Guo QH; Ba JM; Lyu ZH; Dou JT; Mu YM
    Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):72-76. PubMed ID: 34979773
    [No Abstract]    [Full Text] [Related]  

  • 5. Somatic-type Malignancies in testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases.
    Hwang MJ; Hamza A; Zhang M; Tu SM; Pisters LL; Czerniak B; Guo CC
    Am J Surg Pathol; 2022 Jan; 46(1):11-17. PubMed ID: 34334690
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor.
    Blok JM; van der Poel HG; Kerst JM; Bex A; Brouwer OR; Bosch JLHR; Horenblas S; Meijer RP
    World J Urol; 2021 Jun; 39(6):1969-1976. PubMed ID: 32955662
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review.
    Haarsma R; Blok JM; van Putten K; Meijer RP
    Eur J Surg Oncol; 2020 Jun; 46(6):999-1005. PubMed ID: 32173176
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of nuclear NF-κB, transglutaminase2, and ERCC1 as predictors of platinum resistance in testicular tumors.
    Azambuja AA; Engroff P; Silva BT; Zorzetti RCS; Morrone FB
    Int Braz J Urol; 2020; 46(3):353-362. PubMed ID: 32167697
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study.
    Wagner T; Toft BG; Engvad B; Lauritsen J; Kreiberg M; Bandak M; Rosenvilde J; Christensen IJ; Pilt AP; Berney D; Daugaard G
    BMJ Open; 2019 Oct; 9(10):e033713. PubMed ID: 31676661
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genomic Features of Metastatic testicular Sex Cord Stromal Tumors.
    Necchi A; Bratslavsky G; Shapiro O; Elvin JA; Vergilio JA; Killian JK; Ngo N; Ramkissoon S; Severson E; Hemmerich AC; Ali SM; Chung JH; Reddy P; Miller VA; Schrock AB; Gay LM; Ross JS; Jacob JM
    Eur Urol Focus; 2019 Sep; 5(5):748-755. PubMed ID: 31147264
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic Characterization of testicular Germ Cell Tumors Relapsing After Chemotherapy.
    Necchi A; Bratslavsky G; Corona RJ; Chung JH; Millis SZ; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Severson E; Daniel S; Killian JK; Ali SM; Schrock AB; Reddy P; Miller VA; Welsh A; Gay LM; Ross JS
    Eur Urol Focus; 2020 Jan; 6(1):122-130. PubMed ID: 30025711
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. clinical outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.
    Dowling CM; Assel M; Musser JE; Meeks JJ; Sjoberg DD; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
    Urology; 2018 Apr; 114():133-138. PubMed ID: 29410311
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Gonadal function in adult male patients with congenital adrenal hyperplasia.
    Engels M; Gehrmann K; Falhammar H; Webb EA; Nordenström A; Sweep FC; Span PN; van Herwaarden AE; Rohayem J; Richter-Unruh A; Bouvattier C; Köhler B; Kortmann BB; Arlt W; Roeleveld N; Reisch N; Stikkelbroeck NMML; Claahsen-van der Grinten HL;
    Eur J Endocrinol; 2018 Mar; 178(3):285-294. PubMed ID: 29339528
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. IVF outcome in azoospermic cancer survivors.
    Dar S; Orvieto R; Levron J; Haas J; Gat I; Raviv G
    Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():84-87. PubMed ID: 29179011
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]    [Full Text] [Related]  

  • 16. Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in testicular Germ-Cell Tumor Patients.
    Svetlovska D; Miskovska V; Cholujova D; Gronesova P; Cingelova S; Chovanec M; Sycova-Mila Z; Obertova J; Palacka P; Rajec J; Kalavska K; Usakova V; Luha J; Ondrus D; Spanik S; Mardiak J; Mego M
    Clin Genitourin Cancer; 2017 Jun; 15(3):411-416.e2. PubMed ID: 28237180
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. clinical outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.
    Mano R; Becerra MF; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Feldman DR; Sheinfeld J
    J Urol; 2017 Feb; 197(2):391-397. PubMed ID: 27720783
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pelvic Lymph Node Dissection in Patients Treated for Testis cancer: The Memorial Sloan Kettering cancer Center Experience.
    Alanee SR; Carver BS; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
    Urology; 2016 Sep; 95():128-31. PubMed ID: 27235751
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
    Cierna Z; Mego M; Miskovska V; Machalekova K; Chovanec M; Svetlovska D; Hainova K; Rejlekova K; Macak D; Spanik S; Ondrus D; Kajo K; Mardiak J; Babal P
    Ann Oncol; 2016 Feb; 27(2):300-5. PubMed ID: 26598537
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. clinical outcome, Hormonal Status, Gonadotrope Axis, and testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey.
    Bouvattier C; Esterle L; Renoult-Pierre P; de la Perrière AB; Illouz F; Kerlan V; Pascal-Vigneron V; Drui D; Christin-Maitre S; Galland F; Brue T; Reznik Y; Schillo F; Pinsard D; Piguel X; Chabrier G; Decoudier B; Emy P; Tauveron I; Raffin-Sanson ML; Bertherat J; Kuhn JM; Caron P; Cartigny M; Chabre O; Dewailly D; Morel Y; Touraine P; Tardy-Guidollet V; Young J
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2303-13. PubMed ID: 25822101
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.